Picture of Standard BioTools logo

LAB — Standard BioTools News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Fluidigm Corp reports results for the quarter ended in June - Earnings Summary

* Fluidigm Corp  FLDM.OQ  reported a quarterly adjusted loss
of 23 cents​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 19
cents per share.
* Revenue rose 12.3% to $29.25 million from a year ago; 
analysts expected $31.02 million. 
* The mean earnings estimate of analysts had fallen by about 17%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Fluidigm Corp shares had risen by 11.5% this quarter and
gained 14.5% so far this year.
* The company reported a quarterly loss of $17.14 million.
* Wall Street's median 12-month price target for Fluidigm Corp
is $9.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 11:47 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Standard BioTools

See all news